Does Management of Diabetic Ketoacidosis with Subcutaneous Rapid-acting Insulin Reduce the Need for Intensive Care Unit Admission?

Abstract Background In the last 20 years, rapid-acting insulin analogs have emerged on the market, including aspart and lispro, which may be efficacious in the management of diabetic ketoacidosis (DKA) when administered by non-intravenous (i.v.) routes. Clinical Question In patients with mild-to-mod...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of emergency medicine 2015-10, Vol.49 (4), p.530-538
Hauptverfasser:	Cohn, Brian G., MD, Keim, Samuel M., MD, MS, Watkins, Joseph W., MD, Camargo, Carlos A., MD, DrPH
Format:	Artikel
Sprache:	eng
Schlagworte:	diabetic ketoacidosis Diabetic Ketoacidosis - drug therapy DKA Emergency Emergency Medicine - methods Emergency Service, Hospital - statistics & numerical data hospitalization Humans Hypoglycemic Agents - administration & dosage Injections, Subcutaneous insulin Insulin, Short-Acting - administration & dosage intensive care Length of Stay Male Patient Admission - statistics & numerical data Randomized Controlled Trials as Topic Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!